Saturday, April 26, 2025
4/26/2025
Community Project Funding/Congressionally Directed Spending - Construction - Project Director Name Gary Green Project Director Phone Number 336-416-6777 Project Director Email Address gary.green@remdo.org Applicant Website www.remdo.org Descriptive Title of Applicant’s Project RegenMed Hub Test Bed Resources The Regenerative Medicine Development Organization (ReMDO) is requesting $5M for laboratory equipment and other assets required for the clinical translation and commercialization of regenerative medicine and tissue engineered products. ReMDO has pioneered the emerging industry of regenerative medicine, bringing together government, industry and academia to secure US preeminence in this exciting new medical field. The Regenerative Medicine Hub (Hub) was developed through ReMDO and represents a comprehensive series of resources intended to enable the development of cell-, biomaterial-, and tissue-based products, accelerate regulatory approval of these technologies, and assist in the development and execution of commercialization strategies. These services are being provided to both large and small entities with commercial aspirations in the regenerative medicine space. A cornerstone service of the Hub is the Test Bed, a shared laboratory space with state-of-the-art equipment that is currently attracting companies and talent to our region. The Test Bed laboratory provides many of the resources necessary for generating preclinical data and developing clinical manufacturing processes to support regulatory applications. Many large companies have donated critical, specialized equipment and instrumentation to the Test Bed. However, many standard pieces of laboratory equipment are still required to link together these more specialized pieces of equipment into a continuous workflow. The requested equipment represents standard laboratory apparatus, cell culture tools, analytic chemistry instruments and basic imaging capabilities. Also, where gaps exist in specialized technologies, appropriate equipment will be acquired. These pieces of laboratory equipment will complement the resources currently available through the Test Bed and provide participating companies with the tools they need to establish manufacturing and quality assurance processes and procedures. These services are provided at little or no cost, removing economic barriers for start-ups and early-stage companies, as they fight to bring their products to market. Rounding out the Test Bed with the requested equipment will accelerate the rate that these new regenerative medicine technologies are available to US civilians and military personnel, while helping secure a competitive edge for regional and national companies invested in the regenerative medicine space.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).